Mayne Pharma Group Limited (ASX:MYX)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Women's Health	178.37M	142.83M	61.89M	10.57M	7.53M
Women's Health Growth	24.88%	130.78%	485.69%	40.35%	-
Dermatology	154.09M	174.86M	56.99M	92.21M	268.41M
Dermatology Growth	-11.88%	206.81%	-38.19%	-65.64%	-
International	75.64M	70.71M	64.70M	54.37M	42.76M
International Growth	6.97%	9.29%	19.01%	27.15%	0.95%
Metrics Contract Services (MCS)	-	-	-	-	82.09M
Metrics Contract Services (MCS) Growth	-	-	-	-	-0.89%
Total	408.10M	388.40M	183.59M	157.15M	400.78M
Total Growth	5.07%	111.56%	16.82%	-60.79%	-12.30%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
United States	338.85M	322.13M	124.46M	103.27M	358.02M
United States Growth	5.19%	158.81%	20.53%	-71.16%	-13.65%
Australia and New Zealand	41.94M	40.34M	41.20M	33.70M	29.96M
Australia and New Zealand Growth	3.97%	-2.09%	22.24%	12.48%	-
Canada	19.77M	13.37M	9.93M	9.06M	5.45M
Canada Growth	47.92%	34.62%	9.62%	66.15%	-
Europe and Other	4.69M	7.13M	3.60M	6.25M	2.18M
Europe and Other Growth	-34.21%	98.00%	-42.36%	186.03%	-
Asia	2.85M	5.44M	4.40M	4.88M	5.16M
Asia Growth	-47.61%	23.78%	-9.86%	-5.54%	7.47%
Total	408.10M	388.40M	183.59M	157.15M	400.78M
Total Growth	5.07%	111.56%	16.82%	-60.79%	-12.30%

Source: S&P Global Market Intelligence.